• Health

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

December 27, 2024 01:00 ET  | Source: argenx SE VYVDURA® now approved for at-home self-injection in Japan for both generalized…